EcoR1 Capital, LLC Quant / Systematic

Location: San Francisco, CA

CIK: 0001587114 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $318M (93.2% shares, 6.8% debt)

Holdings (31)

FIBROGEN INC 11.6%
Value $37.07M Shares 1,216,473 Est. Cost $24.72 Unrealized
FIVE PRIME THERAPEUTICS INC 9.4%
Value $29.84M Shares 719,000 Est. Cost $36.09 Unrealized
JAZZ PHARMACEUTICALS 8.4%
Value $26.59M Shares 189,200 Est. Cost Unrealized
RETROPHIN INC 7.4%
Value $23.62M Shares 1,224,384 Est. Cost $21.12 Unrealized
ARRAY BIOPHARMA INC 6.8%
Value $21.63M Shares 22,534 Est. Cost $0.96 Unrealized
KURA KURA ONCOLOGY INC 6.5%
Value $20.58M Shares 2,450,000 Est. Cost $10.42 Unrealized 0.0%
ASSEMBLY BIOSCIENCES INC 4.9%
Value $15.76M Shares 2,098,302 Est. Cost $9.53 Unrealized
CYTK CYTOKINETICS INC 4.7%
Value $14.84M Shares 1,418,700 Est. Cost $9.81 Unrealized 0.0%
VALEANT PHARMACEUTICALS INTL 4.0%
Value $12.86M Shares 126,500 Est. Cost Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 4.0%
Value $12.79M Shares 465,118 Est. Cost $17.29 Unrealized +21.8%
EPIZYME INC 3.5%
Value $11.2M Shares 698,900 Est. Cost $19.11 Unrealized
GLPG GALAPAGOS 3.3%
Value $10.52M Shares 167,361 Est. Cost $62.88 Unrealized
KITE PHARMA INC 3.2%
Value $10.23M Shares 166,000 Est. Cost $57.67 Unrealized
FLEX PHARMA INC 3.1%
Value $9.899M Shares 795,088 Est. Cost $19.13 Unrealized
IRWD IRONWOOD PHARMACEUTICALS 3.0%
Value $9.522M Shares 821,531 Est. Cost $9.66 Unrealized 0.0%
NABRIVA THERAPEUTICS AG 2.5%
Value $7.931M Shares 838,680 Est. Cost $9.50 Unrealized
ATYR PHARMA INC 2.4%
Value $7.77M Shares 790,462 Est. Cost $18.52 Unrealized
KINDRED BIOSCIENCES INC 1.5%
Value $4.871M Shares 1,432,765 Est. Cost $7.10 Unrealized
RETROPHIN INC 1.5%
Value $4.709M Shares 244,100 Est. Cost Unrealized
CELLADON CORP 1.3%
Value $4.179M Shares 2,843,170 Est. Cost $1.26 Unrealized
OVASCIENCE INC 1.3%
Value $4.152M Shares 424,979 Est. Cost $9.77 Unrealized
GENVEC INC 1.1%
Value $3.534M Shares 1,920,913 Est. Cost $2.08 Unrealized
CALITHERA BIOSCIENCES INC 1.0%
Value $3.183M Shares 415,480 Est. Cost $15.57 Unrealized
CYTOKINETICS INC 0.9%
Value $2.977M Shares 284,600 Est. Cost Unrealized
ZAFGEN INC 0.7%
Value $2.321M Shares 369,000 Est. Cost $6.29 Unrealized
FORWARD PHARMA A/S 0.6%
Value $1.9M Shares 100,017 Est. Cost $23.61 Unrealized
AKARI THERAPEUTICS PLC 0.5%
Value $1.461M Shares 100,750 Est. Cost $24.00 Unrealized
GILEAD SCIENCES INC 0.4%
Value $1.194M Shares 11,800 Est. Cost Unrealized
NEPHROGENEX INC 0.3%
Value $941K Shares 588,235 Est. Cost $1.60 Unrealized
QLT INC 0.1%
Value $266K Shares 100,000 Est. Cost $3.58 Unrealized
ZAFGEN INC 0.0%
Value $63,000 Shares 10,000 Est. Cost Unrealized